Related Experiment Video
Updated: Jul 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
Nicholas M Brown1, Anna L Goodman2,3, Carolyne Horner4
1Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Abstract:
These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.
Related Concept Videos
Mismatch Repair
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

